Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated:  10/19/2017
Michigan State University
1897
mi
from 91732
East Lansing, MI
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Michigan State University
1897
mi
from 91732
East Lansing, MI
Click here to add this to my saved trials
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated:  10/19/2017
Mt. Sinai Medical School, Hemophilia Comprehensive Care Center
2351
mi
from 91732
New York, NY
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Mt. Sinai Medical School, Hemophilia Comprehensive Care Center
2351
mi
from 91732
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated:  10/19/2017
Children´s Hospital Medical Center Pharmacy, Hemophilia Treatment Center
1880
mi
from 91732
Cincinnati, OH
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Children´s Hospital Medical Center Pharmacy, Hemophilia Treatment Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated:  10/19/2017
Hemophilia Center of Western Pennsylvania
2121
mi
from 91732
Pittsburgh, PA
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Hemophilia Center of Western Pennsylvania
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated:  10/19/2017
Puget Sound Blood Center
961
mi
from 91732
Seattle, WA
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Status: Enrolling
Updated: 10/19/2017
Puget Sound Blood Center
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Phoenix Children's Hospital
345
mi
from 91732
Phoenix, AZ
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Phoenix Children's Hospital
345
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Arkansas Children's Hospital
1463
mi
from 91732
Little Rock, AR
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Arkansas Children's Hospital
1463
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
City of Hope National Medical Center
5
mi
from 91732
Duarte, CA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
City of Hope National Medical Center
5
mi
from 91732
Duarte, CA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Long Beach Memorial Medical Center
21
mi
from 91732
Long Beach, CA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Long Beach Memorial Medical Center
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children´s Hospital Los Angeles, Hemophilia Comprehensive Care Center, Division of Pediatric Hematology/Oncology
15
mi
from 91732
Los Angeles, CA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children´s Hospital Los Angeles, Hemophilia Comprehensive Care Center, Division of Pediatric Hematology/Oncology
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Valley Children's Hospital
230
mi
from 91732
Madera, CA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Valley Children's Hospital
230
mi
from 91732
Madera, CA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children'S Hospital of S.W. Florida
2204
mi
from 91732
Fort Myers, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children'S Hospital of S.W. Florida
2204
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
BIODORON
2318
mi
from 91732
Hollywood, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
BIODORON
2318
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Nemours Children's Clinic - Orlando
2184
mi
from 91732
Orlando, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Nemours Children's Clinic - Orlando
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Tampa Children'S Hospital At St. Joes
2133
mi
from 91732
Tampa, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Tampa Children'S Hospital At St. Joes
2133
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Southern Florida
2134
mi
from 91732
Tampa, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Southern Florida
2134
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Rush-Presbyterian-St. Luke's Medical Center
1726
mi
from 91732
Chicago, IL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Rush-Presbyterian-St. Luke's Medical Center
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children´s Memorial Hospital
1729
mi
from 91732
Chicago, IL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children´s Memorial Hospital
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Indiana Hemophilia and Thrombosis Center
1792
mi
from 91732
Indianapolis, IN
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Indiana Hemophilia and Thrombosis Center
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Iowa Hospitals and Clinics, Iowa Regional Hemophilia Center, Department of Pediatrics
1528
mi
from 91732
Iowa City, IA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Iowa Hospitals and Clinics, Iowa Regional Hemophilia Center, Department of Pediatrics
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Tulane University Hospital & Clinic
1655
mi
from 91732
New Orleans, LA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Tulane University Hospital & Clinic
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Johns Hopkins Hospital
2302
mi
from 91732
Baltimore, MD
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Johns Hopkins Hospital
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Michigan Med. Ctr Htc
1931
mi
from 91732
Ann Arbor, MI
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Michigan Med. Ctr Htc
1931
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Henry Ford Hospital
1965
mi
from 91732
Detroit, MI
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Henry Ford Hospital
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
PHS DEVOS CHILDRENS Hospital
1839
mi
from 91732
Grand Rapids, MI
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
PHS DEVOS CHILDRENS Hospital
1839
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Munson Medical Center
1861
mi
from 91732
Traverse City, MI
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Munson Medical Center
1861
mi
from 91732
Traverse City, MI
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
St. Louis Children's Hospital
1569
mi
from 91732
Saint Louis, MO
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
St. Louis Children's Hospital
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Robert Wood Johnson University Hospital
2410
mi
from 91732
New Brunswick, NJ
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Robert Wood Johnson University Hospital
2410
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Ted R. Montoya Hemophilia Treatment Center
649
mi
from 91732
Albuquerque, NM
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Ted R. Montoya Hemophilia Treatment Center
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
North Carolina Baptist Hospital, Hematology/Oncology Medical Center Boulevard
2125
mi
from 91732
Winston-Salem, NC
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
North Carolina Baptist Hospital, Hematology/Oncology Medical Center Boulevard
2125
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Phs Childrens Hosp Med Ctr Akron
2039
mi
from 91732
Akron, OH
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Phs Childrens Hosp Med Ctr Akron
2039
mi
from 91732
Akron, OH
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children´s Hospital Medical Center Pharmacy, Hemophilia Treatment Center
1880
mi
from 91732
Cincinnati, OH
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children´s Hospital Medical Center Pharmacy, Hemophilia Treatment Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Youngstown HTC
2085
mi
from 91732
Youngstown, OH
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Youngstown HTC
2085
mi
from 91732
Youngstown, OH
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Presbyterian Med Ctr
2373
mi
from 91732
Philadelphia, PA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Presbyterian Med Ctr
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
St. Christopher´s Hospital for Children, Section of Hematology/Oncology
2377
mi
from 91732
Philadelphia, PA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
St. Christopher´s Hospital for Children, Section of Hematology/Oncology
2377
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Tennessee Medical Center
1925
mi
from 91732
Knoxville, TN
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Tennessee Medical Center
1925
mi
from 91732
Knoxville, TN
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Phs-So Tx Hemo Ctr-San Antonio
1188
mi
from 91732
San Antonio, TX
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Phs-So Tx Hemo Ctr-San Antonio
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children's Hospital of The King's Daughters
2336
mi
from 91732
Norfolk, VA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children's Hospital of The King's Daughters
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated:  10/19/2017
Emory University School of Medicine, Dept. of Pediatrics
1922
mi
from 91732
Atlanta, GA
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Emory University School of Medicine, Dept. of Pediatrics
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated:  10/19/2017
Rush University Medical Center
1726
mi
from 91732
Chicago, IL
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Rush University Medical Center
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated:  10/19/2017
Indiana Hemophilia and Thrombosis Center
1792
mi
from 91732
Indianapolis, IN
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Indiana Hemophilia and Thrombosis Center
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated:  10/19/2017
University of Kentucky Hemophilia Treatment Center
1881
mi
from 91732
Lexington, KY
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
University of Kentucky Hemophilia Treatment Center
1881
mi
from 91732
Lexington, KY
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated:  10/19/2017
Brown Cancer Center
1812
mi
from 91732
Louisville, KY
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Brown Cancer Center
1812
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated:  10/19/2017
Brigham and Women´s Hospital, Hematology Division
2576
mi
from 91732
Boston, MA
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Brigham and Women´s Hospital, Hematology Division
2576
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated:  10/19/2017
Rochester General Hospital
2246
mi
from 91732
Rochester, NY
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Rochester General Hospital
2246
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated:  10/19/2017
Hemophilia Center of Western PA
2121
mi
from 91732
Pittsburgh, PA
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Status: Enrolling
Updated: 10/19/2017
Hemophilia Center of Western PA
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials